Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Necroptosis-Inducible Polymeric Nanobubbles for Enhanced Cancer Sonoimmunotherapy

Authors
Um, WooramKo, HyewonYou, Dong GilLim, SeunghoKwak, GijungShim, Man KyuYang, SuahLee, JeongjinSong, YeariKim, KwangmeyungPark, Jae Hyung
Issue Date
4월-2020
Publisher
WILEY-V C H VERLAG GMBH
Keywords
damage-associated molecular patterns; immune checkpoint blockade; necroptosis; reactive oxygen species; sonodynamic therapy
Citation
ADVANCED MATERIALS, v.32, no.16
Indexed
SCIE
SCOPUS
Journal Title
ADVANCED MATERIALS
Volume
32
Number
16
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/56760
DOI
10.1002/adma.201907953
ISSN
0935-9648
Abstract
Necroptosis, caspase-independent programmed necrosis, has emerged as a therapeutic target to make dying cancer cells stimulants for antitumor immune responses. The clinical translations exploiting necroptosis, however, have been limited since most cancer cells downregulate receptor-interacting protein kinase 3 (RIPK3) as a key enzyme for necroptosis. Herein, nanobubbles (NBs) that can trigger RIPK3-independent necroptosis, facilitating cell-membrane rupture via the acoustic cavitation effect are reported. The NBs, imbibing perfluoropentane as the gas precursor, are prepared using an amphiphilic polymer conjugate, composed of PEGylated carboxymethyl dextran as the hydrophilic backbone and chlorin e6 as the hydrophobic sonosensitizer. When exposed to ultrasound, the NBs efficiently promote the release of biologically active damage-associated molecular patterns by inducing burst-mediated cell-membrane disintegration. Consequently, the necroptosis-inducible NBs significantly improve antitumor immunity by maturation of dendritic cells and activation of CD8(+) cytotoxic T cells both in vitro and in vivo. In addition, the combination of NBs and immune checkpoint blockade leads to complete regression of the primary tumor and beneficial therapeutic activity against metastatic tumors in an RIPK3-deficient CT26 tumor-bearing mouse model. Overall, the innovative NB that causes immunogenic cell death of cancer via RIPK3-independent necroptosis is a promising enhancer for cancer immunotherapy.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > KU-KIST Graduate School of Converging Science and Technology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE